| Literature DB >> 19750514 |
Carine Marinach1, Alexandre Alanio, Martine Palous, Stéphanie Kwasek, Arnaud Fekkar, Jean-Yves Brossas, Sophie Brun, Georges Snounou, Christophe Hennequin, Dominique Sanglard, Annick Datry, Jean-Louis Golmard, Dominique Mazier.
Abstract
MALDI-TOF MS can be used for the identification of microorganism species. We have extended its application to a novel assay of Candida albicans susceptibility to fluconazole, based on monitoring modifications of the proteome of yeast cells grown in the presence of varying drug concentrations. The method was accurate, and reliable, and showed full agreement with the Clinical Laboratory Standards Institute's reference method. This proof-of-concept demonstration highlights the potential for this approach to test other pathogens.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19750514 DOI: 10.1002/pmic.200900152
Source DB: PubMed Journal: Proteomics ISSN: 1615-9853 Impact factor: 3.984